210 related articles for article (PubMed ID: 30423338)
21. Physiologically Based Absorption Modeling to Impact Biopharmaceutics and Formulation Strategies in Drug Development-Industry Case Studies.
Kesisoglou F; Chung J; van Asperen J; Heimbach T
J Pharm Sci; 2016 Sep; 105(9):2723-2734. PubMed ID: 26886317
[TBL] [Abstract][Full Text] [Related]
22. Scipion PKPD: an Open-Source Platform for Biopharmaceutics, Pharmacokinetics and Pharmacodynamics Data Analysis.
Sorzano COS; Fonseca-Reyna Y; de la Cruz-Moreno MAP
Pharm Res; 2021 Jul; 38(7):1169-1178. PubMed ID: 34160753
[TBL] [Abstract][Full Text] [Related]
23. Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape.
Schuck E; Bohnert T; Chakravarty A; Damian-Iordache V; Gibson C; Hsu CP; Heimbach T; Krishnatry AS; Liederer BM; Lin J; Maurer T; Mettetal JT; Mudra DR; Nijsen MJ; Raybon J; Schroeder P; Schuck V; Suryawanshi S; Su Y; Trapa P; Tsai A; Vakilynejad M; Wang S; Wong H
AAPS J; 2015 Mar; 17(2):462-73. PubMed ID: 25630504
[TBL] [Abstract][Full Text] [Related]
24. Biomedical journals in Republic of Macedonia: the current state.
Polenakovic M; Danevska L
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(3):43-50. PubMed ID: 25711221
[TBL] [Abstract][Full Text] [Related]
25. Between confidentiality and scientific exchange: the place of publication in drug discovery and pharmaceutical research.
Clozel M
Sci Transl Med; 2011 Jan; 3(67):67cm2. PubMed ID: 21270337
[TBL] [Abstract][Full Text] [Related]
26. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
27. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
28. 10 years for the Journal of Bioinformatics and Computational Biology (2003-2013) -- a retrospective.
Eisenhaber F; Sherman WA
J Bioinform Comput Biol; 2014 Jun; 12(3):1471001. PubMed ID: 24969752
[TBL] [Abstract][Full Text] [Related]
29. From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools.
Willmann S; Lippert J; Schmitt W
Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):159-68. PubMed ID: 16922658
[TBL] [Abstract][Full Text] [Related]
30. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.
Sager JE; Yu J; Ragueneau-Majlessi I; Isoherranen N
Drug Metab Dispos; 2015 Nov; 43(11):1823-37. PubMed ID: 26296709
[TBL] [Abstract][Full Text] [Related]
31. Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience.
Blesch KS; Gieschke R; Tsukamoto Y; Reigner BG; Burger HU; Steimer JL
Invest New Drugs; 2003 May; 21(2):195-223. PubMed ID: 12889740
[TBL] [Abstract][Full Text] [Related]
32. A Learned Society's Perspective on Publishing.
Suzuki K; Edelson A; Iversen LL; Hausmann L; Schulz JB; Turner AJ
J Neurochem; 2016 Oct; 139 Suppl 2():17-23. PubMed ID: 27534728
[TBL] [Abstract][Full Text] [Related]
33. Impact factors of forensic science and toxicology journals: what do the numbers really mean?
Jones AW
Forensic Sci Int; 2003 Apr; 133(1-2):1-8. PubMed ID: 12742682
[TBL] [Abstract][Full Text] [Related]
34. Publication planning: an effective corporate strategy to influence health professionals.
Prescrire Int; 2013 Dec; 22(144):304, 306-7. PubMed ID: 24600737
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
Honório KM; Moda TL; Andricopulo AD
Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
[TBL] [Abstract][Full Text] [Related]
36. In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context.
Lennernäs H; Lindahl A; Van Peer A; Ollier C; Flanagan T; Lionberger R; Nordmark A; Yamashita S; Yu L; Amidon GL; Fischer V; Sjögren E; Zane P; McAllister M; Abrahamsson B
Mol Pharm; 2017 Apr; 14(4):1307-1314. PubMed ID: 28195732
[TBL] [Abstract][Full Text] [Related]
37. Citation classics in nursing journals: the top 50 most frequently cited articles from 1956 to 2011.
Wong EL; Tam WW; Wong FC; Cheung AW
Nurs Res; 2013; 62(5):344-51. PubMed ID: 23995468
[TBL] [Abstract][Full Text] [Related]
38. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
[TBL] [Abstract][Full Text] [Related]
39. Systems Medicine in Pharmaceutical Research and Development.
Kuepfer L; Schuppert A
Methods Mol Biol; 2016; 1386():87-104. PubMed ID: 26677181
[TBL] [Abstract][Full Text] [Related]
40. Reflections on 60 years of publication of the Journal of Neurochemistry.
Turner AJ; Nalivaeva NN; Fonnum F; Tipton KF; Hausmann L; Schulz JB
J Neurochem; 2016 Oct; 139 Suppl 2():7-16. PubMed ID: 27534601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
